Observational study / 2019
Elevated serum TMAO levels were associated with thrombus formation in atrial fibrillation patients with rheumatic heart disease.
Researchers analyzed 117 rheumatic heart disease patients with atrial fibrillation, comparing those with thrombi (n = 25) to those without (n = 92). Serum TMAO levels were significantly higher in the thrombus group (4.55 UM [3.19-4.83] vs. 3.53 UM [2.96-4.25], P = 0.01), and enhanced platelet hyperreactivity was more likely in this group. Receiver operating characteristic analysis showed an area under the curve of 0.661 (P = 0.01, 95% CI: 0.52-0.80), and binary regression analyses demonstrated serum TMAO had predictive power for thrombus formation (P < 0.01, 95% CI: 1.21-3.08).
Shows an association, not proof of cause and effect.
- Study type
- Cross-sectional comparative study
- Who was studied
- 117 consecutive rheumatic heart disease patients with atrial fibrillation
- What was measured
- Thrombus formation, serum TMAO levels, and platelet hyperreactivity
THE PAPER
Gut Microbial Metabolite Trimethylamine N-Oxide Is Related to Thrombus Formation in Atrial Fibrillation Patients.
Gong D, Zhang L, Zhang Y, Wang F, Zhao Z, Zhou X. Am J Med Sci, 2019.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.